Understand what a screening signal means, what it cannot rule out and what diagnostic follow-up could involve.
THE TESTING LAB
Clarity starts with
the right question.
Understand what a test can tell you, whether it fits your situation, and what to do with the result.
YOUR STARTING POINT
What brings you here?
Other goals: prevention, performance and more
Evidence
An evidence label does not mean a test is right for everyone.
Showing 6 of 33 test guides
Compare purpose, preparation and next stepsBlood & biomarkersCBC
Standard of careComplete blood count
A CBC can surface patterns consistent with anemia, infection, inflammation or platelet problems. It is a context test: an out-of-range cell count is a clue, not a diagnosis.
- Collection
- Lab draw
- Relative cost
- $
Blood & biomarkers14
Standard of careComprehensive metabolic panel
The CMP groups 14 common measurements. It can reveal patterns that deserve follow-up, but its liver and kidney values are not complete organ ‘health scores.’
- Collection
- Lab draw
- Relative cost
- $
Blood & biomarkersA+B
Standard of careAdvanced lipids: ApoB + Lp(a)
A standard lipid panel remains useful. ApoB estimates the number of atherogenic particles; Lp(a) is largely inherited and is generally measured at least once in adulthood under current U.S. guidance.
- Collection
- Lab draw
- Relative cost
- $$
Blood & biomarkersGLU
Standard of careGlucose, A1c + fasting insulin
Fasting glucose and A1c are established diabetes tests. Fasting insulin can add metabolic context, but no single universal insulin cutoff diagnoses insulin resistance.
- Collection
- Lab draw
- Relative cost
- $–$$
Blood & biomarkersCRP
Useful in contextHigh-sensitivity CRP
hs-CRP can be a cardiovascular risk enhancer, but it rises with infection, injury, dental disease, obesity and hard exercise. The number never identifies the source on its own.
- Collection
- Lab draw
- Relative cost
- $
Blood & biomarkersTSH
Standard of careThyroid testing
TSH is commonly the first test, often paired or reflexed to free T4. Antibodies and other measures answer narrower questions; a giant panel is not automatically better.
- Collection
- Lab draw
- Relative cost
- $–$$
Guides are educational. Test suitability depends on your clinical context. Cost symbols are relative estimates; confirm the full price with the provider.
SPECIALIZED / ADVANCED ONCOLOGY TESTING
Advanced cancer tests answer very different questions.
RGCC offers liquid-biopsy tests for early-detection signals, circulating-tumor-cell monitoring and treatment-sensitivity profiling. Those uses should never be blended into one promise—or used to replace established screening, pathology, imaging or oncology care.Review circulating tumor cell counts and phenotypes only inside a clinician-led cancer monitoring plan.
Compare laboratory response claims with tumor type, pathology, validated biomarkers and oncology guidelines.
Looking for testing services?Planned options and availability+
TESTING SERVICES / PLANNED
Testing services,
with follow-up built in.
Test purchasing is not available here yet. Explore the planned options below. Services will open only when laboratory quality, local availability, privacy, interpretation and follow-up are verified.The Modern Bio Baseline
CBC · CMP · A1c · core lipids · ApoB · Lp(a) · blood pressure
Partner build in progressCardiometabolic Deep Dive
Advanced lipids · glucose context · kidney risk · blood pressure · optional CAC routing
Partner build in progressHormone + Nutrient Pathway
Staged thyroid, iron, B12/folate/D and sex-hormone testing—not a random mega-panel
Clinician pathwayPerformance Lab
DXA · VO₂/CPET · resting metabolism · strength and function
Facility network plannedSleep Apnea Pathway
Eligibility screen · home study · physician interpretation · treatment routing
Clinical partner plannedFuture test purchases may generate revenue. Commission will never determine whether a test is included, its evidence label or its position. “Do not sell” means exactly that.
How we evaluate a testEvidence, quality, privacy and total cost+
OUR QUALITY STANDARD
Eight questions before
we list a test.
CLIA certification supports laboratory quality in the U.S.; it does not prove that every test is clinically useful. We evaluate the full path from specimen to decision.What exact action can a positive, negative or borderline result change?
Who benefits—and who is likely to be harmed or misled?
What specimen, assay, accreditation and quality controls are used?
Can users collect or prepare correctly without corrupting the result?
Are reference intervals, clinical thresholds and sex/life-stage context kept distinct?
Who owns confirmation, urgent findings and treatment referral?
Can the customer understand storage, sharing, research use and deletion?
Is the full price—including repeat and downstream work—visible before purchase?
READ THE RESULT LIKE A CLINICIAN
A flag is not a diagnosis.
- 01Check the conditions.
Fasting, hydration, illness, exercise, collection and medication timing can change a result.
- 02Separate reference from target.
A laboratory interval describes a population. A clinical threshold guides a decision. An internet “optimal” range may do neither.
- 03Confirm before escalating.
Unexpected, high-impact results often deserve repeat or confirmatory testing with the right method.
- 04Treat the person.
Symptoms, history, anatomy, hormones, pregnancy, medicines and trend remain part of every interpretation.
THE MODERN BIO BRIEF